Introduction
Pemphigus vulgaris is diagnosed by combining a careful clinical assessment with laboratory confirmation. It is an autoimmune blistering disorder in which the immune system produces antibodies against desmogleins, proteins that help skin cells adhere to one another. When this adhesion is disrupted, the outer layers of the skin and the lining of the mouth can separate, forming fragile blisters and erosions. Because several other diseases can cause mouth sores, skin blistering, or painful erosions, accurate diagnosis is important for selecting the right treatment and for distinguishing pemphigus vulgaris from conditions with different causes and risks.
In practice, diagnosis usually begins when a clinician notices features that suggest an intraepidermal blistering disease. Confirmation often requires tissue examination and immunologic testing. The process is not based on a single finding alone; instead, doctors look for a pattern that fits the disease mechanism, the clinical appearance, and the results of specialized tests.
Recognizing Possible Signs of the Condition
Pemphigus vulgaris often first appears in the mouth. Painful erosions on the inner cheeks, gums, palate, tongue, or lips may be persistent and slow to heal. These lesions can begin as thin blisters that rupture quickly, so the blister itself may not always be seen. Patients may report soreness when eating, swallowing, or brushing their teeth. Because oral involvement can precede skin disease by weeks or months, early suspicion often depends on recognizing this pattern rather than waiting for widespread skin findings.
When the skin is involved, the lesions are usually flaccid blisters that break easily, leaving raw, tender erosions. The disease tends to affect normal-appearing skin as well as areas exposed to friction. The blisters are often superficial because the immune attack causes loss of cohesion between keratinocytes, a process called acantholysis. This biological mechanism helps explain why the lesions are fragile and why they rupture before a patient may notice a raised blister.
Clinicians may also suspect pemphigus vulgaris when there is marked pain rather than itching, when lesions are widespread, or when erosions occur in both the mouth and skin. A positive Nikolsky sign, meaning the top layer of skin shears off with gentle pressure or rubbing, may support the suspicion of a blistering disorder. However, this sign is not specific and is not enough on its own to establish the diagnosis.
Medical History and Physical Examination
The diagnostic process begins with a detailed history. A clinician will ask when the sores started, whether they began in the mouth, whether blisters rupture easily, and whether the disease has been persistent or recurrent. The pattern and sequence of lesions are important. Pemphigus vulgaris typically affects mucous membranes first or alongside skin, rather than causing deep, tense blisters.
Doctors also ask about pain, difficulty eating, bleeding from the mouth, and involvement of the eyes, nose, throat, or genital mucosa. Because mucosal disease can be extensive, symptoms such as hoarseness or painful swallowing may point to more widespread involvement. The clinician may review medications, recent illnesses, and exposure history to help exclude other causes of blistering or erosive disease.
Family history is usually less informative than in inherited blistering disorders, but it is still reviewed. A personal history of autoimmune disease may increase suspicion, since pemphigus vulgaris is an autoimmune condition. The physician may also ask about prior treatments, because topical steroids, antibiotics, or antifungal agents may have failed if the underlying problem is autoimmune rather than infectious or inflammatory.
During the physical examination, the clinician inspects the oral cavity, skin, scalp, and other mucosal surfaces. The appearance of shallow erosions, crusted lesions, and fragile blisters is important. Doctors look for the distribution of lesions, whether they are widespread or localized, and whether the surrounding skin appears normal or inflamed. The ease with which lesions extend under pressure may be noted, but the key purpose of the examination is to identify sites suitable for biopsy and to estimate the extent of disease.
Diagnostic Tests Used for Pemphigus vulgaris
Diagnosis is confirmed mainly by tissue-based and immunologic tests. Blood tests and other studies may support the diagnosis, but they do not replace biopsy in most cases. The most important investigations are skin or mucosal biopsy for routine histology and biopsy for direct immunofluorescence.
Routine biopsy and histopathology examine a small sample of affected tissue under the microscope. In pemphigus vulgaris, the pathologist typically sees a suprabasal split, meaning separation occurs just above the basal layer of the epidermis. The basal cells remain attached to the basement membrane and can create a characteristic pattern sometimes described as a row of tombstones. The sample may also show acantholytic cells, which are rounded keratinocytes that have lost their attachments to neighboring cells. These findings support the diagnosis and reflect the disease mechanism.
Direct immunofluorescence is one of the most important confirmatory tests. A biopsy is taken from perilesional skin or mucosa, meaning tissue close to a lesion but not from the eroded center. The sample is treated with fluorescent antibodies that detect deposited immune proteins. In pemphigus vulgaris, direct immunofluorescence usually shows intercellular deposition of IgG, often with complement component C3, in a net-like or chicken-wire pattern throughout the epidermis. This pattern demonstrates that autoantibodies are bound between keratinocytes, which is highly characteristic of pemphigus.
Indirect immunofluorescence is a blood test that looks for circulating antibodies in the patient’s serum. The serum is applied to a substrate, often monkey esophagus or human skin, to see whether the antibodies bind in the same intercellular pattern. This test can support the diagnosis, help assess disease activity, and provide a useful measure for follow-up in some patients. It is especially helpful when tissue biopsy is difficult or when the diagnosis remains uncertain after histology.
Enzyme-linked immunosorbent assay, commonly called ELISA, measures antibodies against specific desmogleins, especially desmoglein 3 and sometimes desmoglein 1. In pemphigus vulgaris, antibodies against desmoglein 3 are particularly important because desmoglein 3 is abundant in mucosal tissues. Some patients also have antibodies to desmoglein 1, which may be associated with more skin involvement. ELISA provides a quantitative result that can help confirm the diagnosis and can sometimes be used to monitor response to treatment over time.
Routine laboratory tests are not diagnostic by themselves but may be ordered to assess the patient’s overall condition and prepare for treatment. These can include complete blood count, liver and kidney function tests, and sometimes tests for infection or baseline immune status. They help identify complications, evaluate fitness for immunosuppressive therapy, and exclude alternative explanations for symptoms. If treatment is being considered, doctors may also check for hepatitis, tuberculosis, or other conditions that could influence medication choice.
Imaging tests are not usually part of the standard diagnostic workup for pemphigus vulgaris. Unlike diseases that involve deeper tissue structures or internal organs, pemphigus vulgaris is primarily a skin and mucous membrane disease. Imaging may be used only if symptoms suggest complications, such as severe swallowing difficulty, infection, or another unrelated condition. In most cases, imaging does not confirm the diagnosis.
Functional tests are also limited in the diagnostic process. There is no single functional test that measures pemphigus vulgaris directly. However, clinicians may assess swallowing function, nutritional status, or ability to maintain oral intake when the mouth and throat are involved. These evaluations do not diagnose the disease, but they can show how significantly it is affecting daily function and whether urgent treatment is needed.
Interpreting Diagnostic Results
Doctors interpret pemphigus vulgaris results by matching the clinical picture with the microscopic and immunologic findings. The strongest diagnostic combination is a patient with fragile mucosal and skin erosions, histology showing suprabasal acantholysis, and direct immunofluorescence demonstrating intercellular IgG and C3. When this pattern is present, the diagnosis is usually secure.
Serologic findings add further support. A positive ELISA for antibodies to desmoglein 3, with or without desmoglein 1, helps confirm the autoimmune target. High antibody levels may correlate with more active disease, though the severity of symptoms does not always match the exact titer. Negative blood antibody tests do not always exclude the condition if the biopsy findings are typical, especially early in disease or in localized cases.
If histology shows an intraepidermal blister but immunofluorescence is negative or unclear, the clinician may consider repeating the biopsy, ensuring that the specimen was taken from the correct site, or re-evaluating the diagnosis. Tissue sampling is sensitive to technique. A biopsy taken from the center of an eroded lesion may be less useful than one taken from the edge or from perilesional tissue for immunofluorescence.
Doctors also interpret results in context. For example, a patient with severe oral erosions and classic immunofluorescence findings may be diagnosed even if skin disease is limited. Conversely, blisters caused by other disorders may not show the same antibody pattern, which helps rule out pemphigus vulgaris.
Conditions That May Need to Be Distinguished
Several conditions can resemble pemphigus vulgaris, especially at the stage where only erosions are visible. One important distinction is from mucous membrane pemphigoid and bullous pemphigoid. These diseases can also cause blistering, but the level of skin separation differs. Pemphigoid disorders typically produce subepidermal blisters rather than suprabasal cleavage, and direct immunofluorescence usually shows linear deposition of immune material along the basement membrane rather than the intercellular pattern seen in pemphigus vulgaris.
Other diagnoses include erosive lichen planus, aphthous ulcers, herpes simplex infection, Stevens-Johnson syndrome, toxic epidermal necrolysis, and paraneoplastic pemphigus. Herpes lesions may resemble oral pemphigus early on, but viral testing and the pattern of lesions help distinguish them. Erosive lichen planus can cause painful mouth sores, but biopsy and immunofluorescence usually show a different inflammatory pattern. Paraneoplastic pemphigus can look similar clinically and immunologically, but it is often associated with an underlying malignancy and has broader mucosal involvement.
Doctors also distinguish pemphigus vulgaris from impetigo, contact dermatitis, drug reactions, and inherited blistering diseases. Age at onset, lesion distribution, presence of fever or systemic illness, and biopsy findings all contribute to the distinction. Because some conditions overlap in appearance, tissue examination is often the deciding step.
Factors That Influence Diagnosis
Several factors can influence how quickly and accurately pemphigus vulgaris is diagnosed. Disease severity is one. Mild disease that is limited to the mouth can be mistaken for common ulcers, candidiasis, or dental inflammation, which may delay biopsy. More extensive skin involvement is easier to suspect as an autoimmune blistering disorder, but severe erosions can also be affected by secondary infection or crusting that obscures the underlying pattern.
Age can matter as well. Pemphigus vulgaris is more common in middle-aged and older adults, so clinicians may not initially consider it in younger patients unless the presentation is highly suggestive. In older adults, other chronic conditions or medication effects may complicate the picture, making careful evaluation more important.
Associated medical conditions and medications may also influence the diagnostic approach. Patients with other autoimmune disorders may raise the index of suspicion. Conversely, a history of new medications can lead doctors to consider drug-induced blistering or severe drug reactions. Immune suppression from illness or treatment may alter serologic results or make infections more likely, which can confuse the early presentation.
Practical factors matter too. The accuracy of biopsy depends on sampling the right site and processing the specimen correctly. If lesions are widespread, clinicians may choose the most informative area for tissue sampling. If oral lesions are present without obvious skin lesions, the biopsy may need to be taken from mucosal tissue by a specialist familiar with blistering disease.
Conclusion
Pemphigus vulgaris is diagnosed through a combination of clinical observation, medical history, physical examination, and specialized testing. The disease is suspected when patients develop fragile mucosal or skin blisters that rapidly become painful erosions, especially when the mouth is involved early. Confirmation depends mainly on biopsy findings and immunologic evidence of antibodies against desmogleins, which reveal the autoimmune basis of the disorder. Histopathology, direct immunofluorescence, and serologic assays together provide a reliable way to identify the disease and distinguish it from other blistering or erosive conditions.
Because the diagnosis affects treatment decisions and long-term management, careful interpretation of the results is essential. A well-executed evaluation allows clinicians to confirm pemphigus vulgaris accurately, assess its extent, and rule out disorders that require different therapy.